Regression or Progression
- 1 January 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 16 (1) , 44-50
- https://doi.org/10.1161/01.atv.16.1.44
Abstract
We have shown that chronic administration of the nitric oxide (NO) precursor l-arginine inhibits atherogenesis in the hypercholesterolemic rabbit. However, the effect of supplemental arginine on preexisting lesions is not known and was the focus of the present study. New Zealand White rabbits received normal chow or 0.5% cholesterol chow for 10 weeks. Subsequently, l-arginine (2.25% in drinking water; ARG group) or vehicle (CHOL group) was administered for an additional 13 weeks, while the high-cholesterol diet was continued. Thoracic aortae were harvested at weeks 10, 14, 18, or 23. Rings of aorta were used to assess NO-dependent vasodilation to acetylcholine. Maximal relaxation to acetylcholine in the CHOL rabbits became progressively attenuated from 53.4% (at week 10) to 17.4% (by week 23). Planimetry of the luminal surface of the aortae from CHOL animals revealed a progressive increase in lesion surface area from 30.3% (at week 10) to 56.5% (by week 23). By contrast, animals in the ARG groups manifested improved endothelium-dependent relaxation associated with a reduction of lesion surface area at 14 and 18 weeks. The arginine-induced improvement in endothelium-dependent relaxation was associated with an increased generation of vascular NO and a reduced generation of vascular superoxide anion. By 23 weeks, 3 of 7 ARG animals had persistent improvement in NO-dependent vasodilation and exhibited a further reduction of lesion surface area to 5.4%. We conclude that hypercholesterolemia induces a progressive loss of NO-dependent vasodilation associated with progressive intimal lesion formation. Administration of l-arginine to animals with preexisting intimal lesions augments vascular NO elaboration, reduces superoxide anion generation, and is associated with a reduction in lesion surface area. This is the first demonstration that restoration of NO activity can induce regression of preexisting intimal lesions and provides evidence that l-arginine therapy may be of potential clinical benefit.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of the Antiatherogenic Effects of Isradipine and Ramipril in Cholesterol-Fed RabbitsJournal of Cardiovascular Pharmacology, 1994
- Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbitJournal of the American College of Cardiology, 1994
- Inhibition of low‐density lipoprotein oxidation by nitric oxide Potential role in atherogenesisFEBS Letters, 1993
- Hypercholesterolemia increases endothelial superoxide anion production.Journal of Clinical Investigation, 1993
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.Journal of Clinical Investigation, 1992
- Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.Journal of Clinical Investigation, 1992
- Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytesBiochemical and Biophysical Research Communications, 1991
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment.Journal of Clinical Investigation, 1989
- Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis.Journal of Clinical Investigation, 1987